Encompass Health Corporation
EHC
$108.95
$0.940.87%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.46% | 11.13% | 11.80% | 11.21% | 11.91% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.46% | 11.13% | 11.80% | 11.21% | 11.91% |
| Cost of Revenue | 7.33% | 8.77% | 9.80% | 9.94% | 11.41% |
| Gross Profit | 14.85% | 14.48% | 14.64% | 13.02% | 12.63% |
| SG&A Expenses | 10.36% | 8.66% | 9.50% | 3.89% | 5.54% |
| Depreciation & Amortization | 9.45% | 9.53% | 12.44% | 10.06% | 9.38% |
| Other Operating Expenses | 12.33% | 11.99% | 10.96% | 10.30% | 9.36% |
| Total Operating Expenses | 8.53% | 9.38% | 10.16% | 9.63% | 10.54% |
| Operating Income | 20.37% | 20.36% | 20.52% | 19.83% | 19.55% |
| Income Before Tax | 27.13% | 25.76% | 27.65% | 26.65% | 23.45% |
| Income Tax Expenses | 28.43% | 16.89% | 15.34% | 10.75% | 13.62% |
| Earnings from Continuing Operations | 26.81% | 28.13% | 30.99% | 31.05% | 26.19% |
| Earnings from Discontinued Operations | 64.29% | 88.03% | 86.18% | 83.74% | 76.67% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -36.91% | -38.81% | -43.70% | -42.88% | -26.94% |
| Net Income | 24.25% | 28.08% | 30.84% | 31.29% | 29.46% |
| EBIT | 20.37% | 20.36% | 20.52% | 19.83% | 19.55% |
| EBITDA | 17.58% | 17.55% | 18.42% | 17.22% | 16.78% |
| EPS Basic | 24.09% | 27.71% | 30.41% | 30.80% | 28.90% |
| Normalized Basic EPS | 19.75% | 17.22% | 18.25% | 17.22% | 24.04% |
| EPS Diluted | 24.29% | 27.80% | 30.41% | 30.58% | 28.26% |
| Normalized Diluted EPS | 20.38% | 17.64% | 18.51% | 17.22% | 23.45% |
| Average Basic Shares Outstanding | 0.55% | 0.63% | 0.58% | 0.50% | 0.43% |
| Average Diluted Shares Outstanding | 0.02% | 0.29% | 0.42% | 0.57% | 0.91% |
| Dividend Per Share | 12.50% | 12.90% | 13.33% | 10.00% | 6.67% |
| Payout Ratio | -0.09% | -0.11% | -0.16% | -0.19% | -0.20% |